Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

Figure 1

Participant progression through the study. ACWY-TT = group of participants who received one dose of MenACWY-TT at Month 0. Men-PS = group of participants who received one dose of the MenACWY polysaccharide vaccine at Month 0. ATP = according to protocol. TVC = total vaccinated cohort. N = number of participants. The numbers of participants withdrawn are given between the TVC vaccination stage and the total cohort for each timepoint during the persistence phase (Year 1, Year 2, and Year 3).

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us